Delay in seeking medical attention after discovery of a breast symptom is an important problem . The thrust of public policy is to encourage early detection and diagnosis of breast cancer in order to deliver prompt treatment and improve outcome. A meta-analysis of 12 studies on delay reported that 34.2% (range 9.9-56.0%) of subjects (total = 8781) delayed more than 3 months (Facione, 1993) . Personal and social variables such as: symptom attribution (Hackett et al, 1973; Averill, 1987; Nichols, 1993), beliefs and attitudes (Antonowsky and Hartman, 1974; Greer, 1974; Timko, 1987) , the nature of symptoms (Adam et al, 1980; MacArthur and Smith, 1981; Caplan, 1995) , health awareness (Huguley and Brown, 1981; Darrow at al, 1987; Zervas et al, 1993) , personality characteristics (Douglas and Druss, 1987; Keinan et al, 1991-92; Phelan et al, 1992) socio-demographic factors (Hackett at al, 1973; Elwood and Moorehead, 1980; Eley at al, 1994 and ethnicity (Richardson et al, 1992; Gregorio et al, 1993; Eley at al, 1994) , may all determine when women present with symptoms and when treatment begins.
We devised and piloted a detailed semi-structured interview to measure delay, presenting symptom(s), mammogram history, previous breast problems, reasons for delay, beliefs and attitudes to cancer. Patient delay was operationally defined as the time elapsing between symptom self-discovery and the first presentation to a medical provider to seek evaluation. Care was taken to avoid encouraging retrospective falsification in estimates of delay, which might be induced by signalling disapproval or conveying any expectation on when presentation was expected. Subjects were helped to date symptom onset with specific memory probes and anchor points. System delay was defined as the time between a woman's first medical evaluation of self-discovered breast symptoms and first consultation with a breast specialist, and was assessed by recording dates of first presentation in primary care and time for referral to reach the Breast Clinic. Dates were verified using general practitioner (GP) and hospital records. The General Health Questionnaire (GHQ-12) (Goldberg and Williams, 1988 ) was used to measure psychiatric morbidity and the 'Health Awareness Assessment', designed and piloted for this study, elicited patients' intention to seek medical consultation for a range of ten different physical symptoms including a breast lump, persistent headache, coughing up blood, irregular periods. Clinical staff used a short semi-structured interview to collate patients' full medical history and risk factors for breast cancer.
Social and demographic data included marital status, religion, ethnicity (by self-definition), occupation, years of education and educational attainment. Information about appropriate utilization of mammographic screening services was collected, as was failure to keep clinic appointments for the current episode, GP attendance in the previous year and preference for a female consultant.
RESULTS

Sample characteristics
The characteristics of the sample are shown in Table 1 . Eightyseven (12.6%) women had a final diagnosis of breast cancer.
Overall, 421 women (60.8% of whole sample) presented with a breast lump with or without pain, 62 of whom were later diagnosed with breast cancer (χ 2 = 4.54, P = 0.03). Breast pain, with or without another associated breast symptom occurred in a similar proportion of patients irrespective of final diagnosis. Other symptoms such as 'tenderness', 'thickening', nipple discharge, skin rashes etc., occurred more frequently in the non-cancer group (see Table 1 ).
Women were regarded as having missed a mammogram if, according to their age (i.e. 50-64 years) they would have been expected to have been invited to participate in the National Screening Programme. This percentage was significantly higher for breast cancer patients when compared with women with other breast symptoms. Only 21 women failed to keep clinic appointments for the current episode (one of whom turned out to have cancer).
Distribution of patient and system delay
Results are given in Table 2 . For the total sample (n = 692) median patient delay was 13 days. The range was from 0 to 10 958 days. The distribution was highly skewed with a few subjects showing extreme delay hence logarithmic transformation was undertaken for presentation and statistical analyses (Figure 1 ). Patients who were subsequently diagnosed as suffering from malignant disease showed a slight non-significant tendency to present earlier than those whose symptoms were benign. When extreme delay was considered, 5.0% of patients with benign breast symptoms versus 9.2% of cancer patients delayed presentation over 1 year (χ 2 = 8.5, df = 3, P = 0.04).
Regarding system delay, the majority of patients were seen in the clinic within 2-4 weeks, but others were sent away with no further investigation or referral; median 18 days, range was from 0 to 2889 days (8.1 years) ( Figure 2 and Table 2 ). Patients with breast symptoms of a benign nature experienced significantly greater system delay. Cancer patients were twice as likely to see a breast specialist within three weeks of contact with their GP than patients who had benign breast symptoms, suggesting that GPs are more alert to certain symptoms and signs that were later shown to be caused by malignancy (24 (27.6%) vs 237 (39.2%); χ 2 = 5.4, df = 1, P = 0.02). There was no correlation between patient and system delay (Kendall's Tau: r = 0.05).
Long patient delay analysis
For statistical analyses, patients were divided into 'long' and 'short' delayers. Long delayers were those presenting >27 days from symptom discovery. The cut-off point of 27 days used to define delay in this study was prompted by the preferred statistical analytic technique to explore the data (logistic regression). Only 17% of patients in the present study delayed over 3 months, compared to 35% delaying for 4 weeks or more. Using the larger group maximizes the chances of reliably explaining the observed variation in delay.
Presenting symptom and delay
Women's presenting symptoms were investigated in relation to short and long presentation delay, and results of an analysis of variance showed no significant differences (F = 0.10, df = 4, P = 0.4). However, when presenting symptom was simply divided into lump/no lump and pain/no pain, statistically significant differences in delay emerged. Sixty-six per cent of women with a breast lump presented to their doctor within 27 days from symptom discovery, compared to 34% of those without a lump (χ 2 = 13.9, df = 1, P = 0.001). Of patients with breast tenderness or pain, 76% presented to their doctor within 27 days from symptom discovery, compared to 62% of those without pain (χ 2 = 8.8, df = 1, P = 0.003).
Reasons for delay
Whole sample
Reasons given by patients to justify their delay are given in Table  3 . When patients mentioned more than one reason, we identified the most important by further questioning. Over half of 'long delays' occurred in women who believed that their symptom was not serious and therefore did not require medical attention. Women who delayed specifically because they feared a cancer diagnosis had the highest median delay (91 days). When a reason for delay was not given and when women presented as soon as possible, delay reason was coded as 'other'.
Cancer vs non-cancer Overall, cancer patients and patients with benign breast disease differed significantly in their reasons for delay (χ 2 = 13.3, df = 4, P = 0.01): patients who subsequently were diagnosed with cancer delayed presentation because they were scared more often than women with benign conditions (11.5% and 4.0% respectively) and were less likely to consider their symptom to be 'not serious' (21.8% vs 35.0%).
When 'long delayers' only were considered, cancer patients delayed presentation because they were scared more often than women with benign disease (22.2% and 5.1% respectively: χ 2 = 10.8, df = 1, P = 0.001) ( Table 4 ). There was no significant difference between the groups in terms of thinking that the symptom would go away (χ 2 = 1.6, df = 1, P = 0.2) or other beliefs. These results suggest that some women anticipated their eventual diagnosis of breast cancer. We examined this further by cross-tabulating attribution (benign/malignant) by diagnosis, for all subjects. Of people with benign breast symptoms, 108 (17.8%) thought they had cancer. Of those 87 women with cancer, 55 (63.2%) suspected a correct diagnosis; 32 (36.8%) thought they had a less serious condition (χ 2 = 16.9, df = 1, P = 0.001).
In order to investigate psychosocial and demographic variables associated significantly with long patient delay (log patient delay (days) + 1), a logistic regression model was constructed. The results and significant variables are shown in Table 5 . 'Long delayers' were characterized by poor health awareness about hypothetical breast symptoms, the tendency to minimize the significance of their symptom and by fear and higher levels of psychological morbidity (GHQ-12 scores). Variables entered which did not contribute noticeably to the variance included marital status, social class, ethnicity, educational attainment, psychiatric history, history of benign breast symptoms, family history and previous mammograms. Patient delay in cancer patients and those with benign breast symptoms was predicted by the same variables, therefore a breakdown according to diagnosis is not given.
As argued above, a cut-off of 27 days was used to define long delay. However, to aid comparison with other studies the same analysis was conducted with a 90-day cut-off. The maximum rescaled R 2 was 0.21. The same explanatory variables emerged but with additions, namely preferring a female consultant: odds ratio (OR) 2.16 (95% confidence intervals (CI) 1.3-3.5); having a recent GP consultation (within 1 year of current episode): OR 1.35 (95% CI 1.03-1.78); and presenting with a lump: OR 0.56 (95% CI 0.36-0.89).
A linear regression model was constructed to predict changes in log system delay (Table 6 ). Women with longer patient delays and those who failed to keep their appointment tended to be processed more slowly by the system. Predictors of decreased system delay included subsequent cancer diagnosis, patients' attribution of cancer to their symptom and presence of a breast lump at the time of referral. Other socio-demographic factors including age, socioeconomic status and ethnicity, were not important predictors. We investigated the variables predictive of a positive cancer diagnosis using logistic regression (R 2 = 0.36). After correcting for age and demographic variables, the main results were that women later diagnosed with breast cancer were more likely to have a delayed presentation due to fear than those with benign disease, OR 2.69 (95% CI 0.98-6.9), to have thought their symptom was due to cancer, OR 2.50 (95% CI 1.4-4.6), and were significantly less likely to have had a screening mammogram OR 2.28 (95% CI 1.06-5.0).
DISCUSSION
Patient delay
Based on a large consecutive series of symptomatic women attending a hospital breast clinic, we found that psychological rather than demographic factors (Antonowsky and Hartman, 1974; Williams et al, 1976; Burgess et al, 1998) were the main predictors of delay in presentation of 4 weeks or more. Ethnicity did not significantly influence either patient or system delay, in contrast to reports from the USA (Richardson et al, 1992; Hunter et al, 1993) , and marital status was not found to influence delay (see also Ramirez et al, 1999) .
Others have taken 3 months as the criterion for long delay. Relatively few patients in this and another recent UK survey (Burgess et al, 1998) delayed for this long, moreover, the factors related to 4 weeks or more delay were also related to delay of 3 months. Additional factors emerged with longer delays such as preference for a female consultant, also highlighted in relation to attitudes to breast examination (Haigney et al, 1997) . Another was having had a recent consultation with the GP, which may have inhibited patients from 'bothering' the doctor again. Psychological distress -as indexed by an expression of fear of cancer and by GHQ scores -was associated with long delays, especially in those who did indeed turn out to have breast cancer. Not unexpectedly, those least anxious about their symptoms also delayed seeking medical attention. This pattern is predicted by an arousal model of human behaviour (Tones, 1980) . Anxiety and depression were assessed at interview, so may also have coloured explanations given for previous behaviour and may be different from that at the time of symptom discovery. Similarly, patients' tendency to procrastinate when faced with the hypothetical scenario of discovering a breast lump, was inferred retrospectively with respect to patient delay, from the Health Awareness Assessment.
Health education campaigns state that a breast lump is a possible indicator of breast cancer. The proportion of women actually presenting with such a symptom in this study was 61%. Women with lumps had less patient and system delay, supporting our hypothesis and previous studies (MacArthur and Smith, 1981; Gould-Martin et al, 1982) .
Nine out of 10 women (497/529) attending the clinic thinking they had a benign condition were correct, and two out of three women (108/163) who suspected they had cancer were incorrect. Nevertheless, women later diagnosed with breast cancer seemed to have a strong inkling that this was the case prior to definitive tissue diagnosis; they were interviewed after having seen a primary care practitioner, who may have cued them to the suspicion of malignancy. Despite this and contrary to previous studies (Greer, 1974) most of the women in this study subsequently diagnosed with breast cancer did not present earlier than those with a benign condition and a few delayed presentation to a worrying degree, citing fear of diagnosis as an explanation. Overall, the results suggest that factors causing delay are the same in those who develop cancer and those who do not.
A relationship between delay in symptomatic presentation and compliance with mammographic screening might have been expected since the psychological processes involved appear to overlap (Fink, 1977) . Our data on mammograms were based entirely on self reports so may not have been reliable. However, no such relationship was detected. Some women claimed not to have received an offer of screening and this may have been the result of administrative failures. The current study was restricted to those who had symptoms although it covered an age range which included that which is targeted for screening (50-64 years). Caution is needed before extrapolating our findings to women diagnosed through screening or other age groups; indeed restricting our sample to those of 75 years of age or less may have obscured a relationship between age and delay found in a recent systematic review . Furthermore, differences in patient (and system) delay in other groups, such as those with and without a positive family history were not detected.
System delay
This was not predicted by socio-demographic variables and our model succeeded in explaining only 11% of the variance. System delay was predicted by increased patient delay and missed appointments. Failure to attend an outpatient appointment may, however, be due in part to administrative complications, such as incorrect addresses. Further audit of this is necessary. The system we studied did not show a social class, ethnic or education bias. Furthermore, apart from a few unfortunate exceptions where patients appeared to have been falsely reassured, i.e. not referred on immediately, the system responded appropriately more quickly to patients who turned out to have cancer.
What are the implications from this study for health promotion? There is a delicate balance between scaring women away from their doctors on the one hand (especially when they suspect the worst), and adding to a false sense of reassurance, thus taking away any motivation to come forward. Women should be encouraged to think of their breast symptom as 'urgent but not necessarily serious' and should be prompted to present to their doctor as soon as possible. Diagnosis should be cast in as positive a light as possible. Although breast lumps are the most common symptom, others are also predictive of cancer and perhaps these should be mentioned in health awareness campaigns. Regarding system delay, administrative arrangements should be regularly monitored in terms of national targets. The availability of female consultants should be increased to meet patient preferences. Finally, health care professionals should be alert to women who are hesitant to present, and in such circumstances should themselves act swiftly.
